This company is no longer active
Diffusion Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$25.86m |
Equity | US$24.05m |
Total liabilities | US$2.27m |
Total assets | US$26.32m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DP81's short term assets ($26.3M) exceed its short term liabilities ($2.3M).
Long Term Liabilities: DP81 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DP81 is debt free.
Reducing Debt: DP81 has no debt compared to 5 years ago when its debt to equity ratio was 8.7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DP81 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: DP81 has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 6.2% each year.